human holo transferrin Search Results


94
TargetMol unlabeled holo human transferrin targetmoi
Unlabeled Holo Human Transferrin Targetmoi, supplied by TargetMol, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/Holo-Human+transferrin/pm42207639-298-32-35
Average 94 stars, based on 1 article reviews
unlabeled holo human transferrin targetmoi - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

94
R&D Systems human holo transferrin
Human Holo Transferrin, supplied by R&D Systems, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/Human+Holo-Transferrin+Protein%2C+CF/pmc04628786-108-19-21
Average 94 stars, based on 1 article reviews
human holo transferrin - by Bioz Stars, 2026-11
94/100 stars
  Buy from Supplier

90
Lee Biosolutions di ferric iron
Di Ferric Iron, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/Holo+Transferrin%2C+Human+Serum/pmc04854542-309-37-39
Average 90 stars, based on 1 article reviews
di ferric iron - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

92
MedChemExpress holo transferrin
Holo Transferrin, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 92/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/Holo-Human+transferrin/pm37480032-62-24-33
Average 92 stars, based on 1 article reviews
holo transferrin - by Bioz Stars, 2026-11
92/100 stars
  Buy from Supplier

90
Scipac Ltd holo-human transferrin
Holo Human Transferrin, supplied by Scipac Ltd, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/holo+human+transferrin/pmc03590085-57-35-37
Average 90 stars, based on 1 article reviews
holo-human transferrin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Akron Biotech human holo-transferrin (10 mg in 1 ml of pbs)
In situ cleavage of genomic target site by <t>transferrin-ZFN1/transferrin-ZFN2</t> pair. ( A ) Schematic diagram of the U2OS 2-6-3 transgene array, modified from . Approximately 200 copies of this array are integrated at a single genomic site. Each repeat in the tandem array contains 256 copies of the lac operator recognition site and a single ZFN-cleavable CFP cDNA sequence. The transgene is not induced in these experiments, and several other elements not used here, and relevant only to gene expression are depicted in gray: 96 copies of a tetracycline response element, a minimal CMV promoter, a peroxisomal targeting signal (SKL), 24 copies of the MS2 translational operator, a rabbit beta-globin intron/exon module and a polyadenylation signal . ( B ) Merged images of fluorescent lac repressor (LacI-ECFP) and the DSB marker 53BP1 in untreated control cells (top) or in two representative fields of transferrin-ZFN treated cells (two lower rows). Insets show colocalization of Laci-ECFP and anti-53BP1 staining in treated cells. ( C ) Tabulation of co-localization in the indicated numbers of untreated and transferrin-ZFN treated U2OS 2-6-3 cells.
Human Holo Transferrin (10 Mg In 1 Ml Of Pbs), supplied by Akron Biotech, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/human+holo+transferrin++10+mg+in+1+ml+of+pbs+/pmc03799454-45-2-11
Average 90 stars, based on 1 article reviews
human holo-transferrin (10 mg in 1 ml of pbs) - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Applichem inc holo-transferrin
In situ cleavage of genomic target site by <t>transferrin-ZFN1/transferrin-ZFN2</t> pair. ( A ) Schematic diagram of the U2OS 2-6-3 transgene array, modified from . Approximately 200 copies of this array are integrated at a single genomic site. Each repeat in the tandem array contains 256 copies of the lac operator recognition site and a single ZFN-cleavable CFP cDNA sequence. The transgene is not induced in these experiments, and several other elements not used here, and relevant only to gene expression are depicted in gray: 96 copies of a tetracycline response element, a minimal CMV promoter, a peroxisomal targeting signal (SKL), 24 copies of the MS2 translational operator, a rabbit beta-globin intron/exon module and a polyadenylation signal . ( B ) Merged images of fluorescent lac repressor (LacI-ECFP) and the DSB marker 53BP1 in untreated control cells (top) or in two representative fields of transferrin-ZFN treated cells (two lower rows). Insets show colocalization of Laci-ECFP and anti-53BP1 staining in treated cells. ( C ) Tabulation of co-localization in the indicated numbers of untreated and transferrin-ZFN treated U2OS 2-6-3 cells.
Holo Transferrin, supplied by Applichem inc, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/holo+transferrin+human/pm29669740-230-54-55
Average 90 stars, based on 1 article reviews
holo-transferrin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Nacalai recombinant human holo-transferrin

Recombinant Human Holo Transferrin, supplied by Nacalai, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/recombinant+human+holo+transferrin/pmc07580236-57-0-4
Average 90 stars, based on 1 article reviews
recombinant human holo-transferrin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Mebiopharm human holo-transferrin

Human Holo Transferrin, supplied by Mebiopharm, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/human+holo+transferrin/us08778679-235-84-87
Average 90 stars, based on 1 article reviews
human holo-transferrin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
SERVA Electrophoresis digested transferrin (human (holo)) serva electrophoresis 36756

Digested Transferrin (Human (Holo)) Serva Electrophoresis 36756, supplied by SERVA Electrophoresis, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/digested+transferrin++human++holo+++serva+electrophoresis+36756/pm31409882-301-5-8
Average 90 stars, based on 1 article reviews
digested transferrin (human (holo)) serva electrophoresis 36756 - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

90
Merck & Co human holo-transferrin
(A) A549_Rab11a-mCherry cells were stained for MYOF and imaged. The yellow inset is shown magnified below. Scale bar 10 µm. (B) Pearson’s correlation coefficient analysis between MYOF and Rab11a in single cells, with different shaped points indicating individual cells from different replicates. (C) Western blot of protein expression in siRNA-treated A549 cells 48h post transfection. (D) siRNA-treated A549 cells stained for MYOF 48h post-transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (E) siRNA treated A549_Rab11a-mCherry cells imaged for Rab11a-mCherry 48h post transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (F) siRNA treated A549_Rab11a-mCherry cells transfected for 48h before cells were serum starved for 30’ at 4°C, incubated at 37°C with Atto647-labelled <t>transferrin</t> (Tfn) for 30’ and immediately fixed on ice. Scale bar 10 µm. (G-I) Measurement of the largest signal (G, MYOF; H, Rab11a; I, Tfn) accumulation in each cell, measured by automated thresholding based on image entropy. All experiments consist of 3 biological replicates and error bars represent standard deviation.
Human Holo Transferrin, supplied by Merck & Co, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/human+holo+transferrin/holo+transferrin/bio_rxiv__2024__07__02__601679-276-0-2
Average 90 stars, based on 1 article reviews
human holo-transferrin - by Bioz Stars, 2026-11
90/100 stars
  Buy from Supplier

Image Search Results


In situ cleavage of genomic target site by transferrin-ZFN1/transferrin-ZFN2 pair. ( A ) Schematic diagram of the U2OS 2-6-3 transgene array, modified from . Approximately 200 copies of this array are integrated at a single genomic site. Each repeat in the tandem array contains 256 copies of the lac operator recognition site and a single ZFN-cleavable CFP cDNA sequence. The transgene is not induced in these experiments, and several other elements not used here, and relevant only to gene expression are depicted in gray: 96 copies of a tetracycline response element, a minimal CMV promoter, a peroxisomal targeting signal (SKL), 24 copies of the MS2 translational operator, a rabbit beta-globin intron/exon module and a polyadenylation signal . ( B ) Merged images of fluorescent lac repressor (LacI-ECFP) and the DSB marker 53BP1 in untreated control cells (top) or in two representative fields of transferrin-ZFN treated cells (two lower rows). Insets show colocalization of Laci-ECFP and anti-53BP1 staining in treated cells. ( C ) Tabulation of co-localization in the indicated numbers of untreated and transferrin-ZFN treated U2OS 2-6-3 cells.

Journal: Nucleic Acids Research

Article Title: Receptor-mediated delivery of engineered nucleases for genome modification

doi: 10.1093/nar/gkt710

Figure Lengend Snippet: In situ cleavage of genomic target site by transferrin-ZFN1/transferrin-ZFN2 pair. ( A ) Schematic diagram of the U2OS 2-6-3 transgene array, modified from . Approximately 200 copies of this array are integrated at a single genomic site. Each repeat in the tandem array contains 256 copies of the lac operator recognition site and a single ZFN-cleavable CFP cDNA sequence. The transgene is not induced in these experiments, and several other elements not used here, and relevant only to gene expression are depicted in gray: 96 copies of a tetracycline response element, a minimal CMV promoter, a peroxisomal targeting signal (SKL), 24 copies of the MS2 translational operator, a rabbit beta-globin intron/exon module and a polyadenylation signal . ( B ) Merged images of fluorescent lac repressor (LacI-ECFP) and the DSB marker 53BP1 in untreated control cells (top) or in two representative fields of transferrin-ZFN treated cells (two lower rows). Insets show colocalization of Laci-ECFP and anti-53BP1 staining in treated cells. ( C ) Tabulation of co-localization in the indicated numbers of untreated and transferrin-ZFN treated U2OS 2-6-3 cells.

Article Snippet: For conjugation, human holo-transferrin (10 mg in 1 ml of PBS) (Akron Biotechnology, Boca Raton, FL) was reacted with 1 mM sulfosuccinimidyl 6-[3′(2-pyridyldithio)-propionamido] hexanoate (SPDP; Pierce Biotechnology, Rockford, IL, USA) for 1 h at room temperature.

Techniques: In Situ, Modification, Sequencing, Expressing, Marker, Staining

Receptor mediated delivery concept. ( A ) Conjugation scheme. Human holo-transferrin was activated by incubation with SPDP, and conjugates were isolated and incubated with purified ZFN as described in ‘Materials and Methods’ section. A scissile disulfide bond joins the transferrin and the ZFN. ( B ) Cellular delivery. 1. The transferrin-nuclease complex binds to its cognate receptor, which induces uptake of the cargo to the cell interior in the early recycling endosome. 2. Under the reducing conditions of the endosomal milieu, the ZFN protein is released from the ligand-receptor complex by ‘self-immolation’ of the disulfide bond. 3. ZFN protein escapes the endosome. 4. ZFN protein translocates to the cell nucleus where the two ZFN subunits bind to opposing DNA strands and cleave the target sequence. Pm, plasma membrane; End, endosome; Nuc, nucleus.

Journal: Nucleic Acids Research

Article Title: Receptor-mediated delivery of engineered nucleases for genome modification

doi: 10.1093/nar/gkt710

Figure Lengend Snippet: Receptor mediated delivery concept. ( A ) Conjugation scheme. Human holo-transferrin was activated by incubation with SPDP, and conjugates were isolated and incubated with purified ZFN as described in ‘Materials and Methods’ section. A scissile disulfide bond joins the transferrin and the ZFN. ( B ) Cellular delivery. 1. The transferrin-nuclease complex binds to its cognate receptor, which induces uptake of the cargo to the cell interior in the early recycling endosome. 2. Under the reducing conditions of the endosomal milieu, the ZFN protein is released from the ligand-receptor complex by ‘self-immolation’ of the disulfide bond. 3. ZFN protein escapes the endosome. 4. ZFN protein translocates to the cell nucleus where the two ZFN subunits bind to opposing DNA strands and cleave the target sequence. Pm, plasma membrane; End, endosome; Nuc, nucleus.

Article Snippet: For conjugation, human holo-transferrin (10 mg in 1 ml of PBS) (Akron Biotechnology, Boca Raton, FL) was reacted with 1 mM sulfosuccinimidyl 6-[3′(2-pyridyldithio)-propionamido] hexanoate (SPDP; Pierce Biotechnology, Rockford, IL, USA) for 1 h at room temperature.

Techniques: Conjugation Assay, Incubation, Isolation, Purification, Sequencing

Production and cleavage activity of transferrin-ZFN conjugates. ( A ) Purification. S-75 gel filtration chromatography of transferrin and ZFN containing reaction mix. Elution positions of conjugates and reactants are indicated. ( B ) SDS–PAGE analysis of fractions from panel (A) as indicated. Sample buffer was either non-reducing (top) or reducing (bottom). Reduction of transferrin-ZFN2 (tf-ZFN2) yields free ZFN2, free transferrin and an additional band migrating just ahead of free transferrin, the identity of which is not known. ( C ) ZFN and tf-ZFN DNA cleavage activity. Figure shows titration of ZFN2 or tf-ZFN2 with ZFN1 held constant. Titrations of ZFN1 and tf-ZFN1 were similar ( Supplementary Figure S2 ). Position of substrate and products are indicated. ( D ) Quantification of data from panel (C) showing substrate and products as a percentage of total DNA in each lane. ( E ) Cleavage activity of tf-ZFN1 and tf-ZFN2 in combination.

Journal: Nucleic Acids Research

Article Title: Receptor-mediated delivery of engineered nucleases for genome modification

doi: 10.1093/nar/gkt710

Figure Lengend Snippet: Production and cleavage activity of transferrin-ZFN conjugates. ( A ) Purification. S-75 gel filtration chromatography of transferrin and ZFN containing reaction mix. Elution positions of conjugates and reactants are indicated. ( B ) SDS–PAGE analysis of fractions from panel (A) as indicated. Sample buffer was either non-reducing (top) or reducing (bottom). Reduction of transferrin-ZFN2 (tf-ZFN2) yields free ZFN2, free transferrin and an additional band migrating just ahead of free transferrin, the identity of which is not known. ( C ) ZFN and tf-ZFN DNA cleavage activity. Figure shows titration of ZFN2 or tf-ZFN2 with ZFN1 held constant. Titrations of ZFN1 and tf-ZFN1 were similar ( Supplementary Figure S2 ). Position of substrate and products are indicated. ( D ) Quantification of data from panel (C) showing substrate and products as a percentage of total DNA in each lane. ( E ) Cleavage activity of tf-ZFN1 and tf-ZFN2 in combination.

Article Snippet: For conjugation, human holo-transferrin (10 mg in 1 ml of PBS) (Akron Biotechnology, Boca Raton, FL) was reacted with 1 mM sulfosuccinimidyl 6-[3′(2-pyridyldithio)-propionamido] hexanoate (SPDP; Pierce Biotechnology, Rockford, IL, USA) for 1 h at room temperature.

Techniques: Activity Assay, Purification, Filtration, Chromatography, SDS Page, Titration

Cellular delivery of transferrin-conjugated ZFN. ( A ) ZFN protein levels in HEK293/A658 cells visualized by indirect immunofluorescence using ant-FLAG primary antibody. Cells were transfected with ZFN1/2 cDNA. Alternatively, they were incubated with 100 nM transferrin-ZFN1, or 100 nM non-conjugated ZFN1, as indicated, for 1 h at 37°C. Competition experiments were performed with a 10-fold molar excess of free holo-transferrin. Z-stacks were collected with a Deltavision microscope and deconvolved. Each panel corresponds to a single Z-section. ( B ) Quantification of nuclear uptake of tf-ZFN1 protein based on anti-FLAG fluorescence intensity. HEK293/A658 cells were incubated for 60 min with various concentration of tf-ZFN1 as indicated, then fixed and stained. Measurements were based on one representative Z-section from each of 25 cells total (from five different fields) for each experimental group. Graph shows mean and standard deviation. ( C ) Quantification of nuclear uptake of tf-ZFN1 as in panel (B), except that tf-ZFN1 concentration was fixed at 100 nM, and continuous incubation was performed for the indicated times. ( D ) ZFN protein levels in U2OS 2-6-3 human osteosarcoma cells. Cells were transfected with ZFN1/2 cDNA expression plasmid or incubated with tf-ZFN1 (100 nM, 60 min) as indicated. ( E ) Same as panel (D) but with murine adult fibroblasts. ( F ) Same as panel (D) but with primary human HSPCs (CD34 + ). ( G ) Same as panel (D) but with primary mouse HSPCs (LSK). Panels compare ZFN distribution with labeled free transferrin, note difference in localization. Scale bars, 10 μm for panels (A–E), 5 μm for panels (F) and (G).

Journal: Nucleic Acids Research

Article Title: Receptor-mediated delivery of engineered nucleases for genome modification

doi: 10.1093/nar/gkt710

Figure Lengend Snippet: Cellular delivery of transferrin-conjugated ZFN. ( A ) ZFN protein levels in HEK293/A658 cells visualized by indirect immunofluorescence using ant-FLAG primary antibody. Cells were transfected with ZFN1/2 cDNA. Alternatively, they were incubated with 100 nM transferrin-ZFN1, or 100 nM non-conjugated ZFN1, as indicated, for 1 h at 37°C. Competition experiments were performed with a 10-fold molar excess of free holo-transferrin. Z-stacks were collected with a Deltavision microscope and deconvolved. Each panel corresponds to a single Z-section. ( B ) Quantification of nuclear uptake of tf-ZFN1 protein based on anti-FLAG fluorescence intensity. HEK293/A658 cells were incubated for 60 min with various concentration of tf-ZFN1 as indicated, then fixed and stained. Measurements were based on one representative Z-section from each of 25 cells total (from five different fields) for each experimental group. Graph shows mean and standard deviation. ( C ) Quantification of nuclear uptake of tf-ZFN1 as in panel (B), except that tf-ZFN1 concentration was fixed at 100 nM, and continuous incubation was performed for the indicated times. ( D ) ZFN protein levels in U2OS 2-6-3 human osteosarcoma cells. Cells were transfected with ZFN1/2 cDNA expression plasmid or incubated with tf-ZFN1 (100 nM, 60 min) as indicated. ( E ) Same as panel (D) but with murine adult fibroblasts. ( F ) Same as panel (D) but with primary human HSPCs (CD34 + ). ( G ) Same as panel (D) but with primary mouse HSPCs (LSK). Panels compare ZFN distribution with labeled free transferrin, note difference in localization. Scale bars, 10 μm for panels (A–E), 5 μm for panels (F) and (G).

Article Snippet: For conjugation, human holo-transferrin (10 mg in 1 ml of PBS) (Akron Biotechnology, Boca Raton, FL) was reacted with 1 mM sulfosuccinimidyl 6-[3′(2-pyridyldithio)-propionamido] hexanoate (SPDP; Pierce Biotechnology, Rockford, IL, USA) for 1 h at room temperature.

Techniques: Immunofluorescence, Transfection, Incubation, Microscopy, Fluorescence, Concentration Assay, Staining, Standard Deviation, Expressing, Plasmid Preparation, Labeling

Transferrin-ZFN mediated gene correction in HEK293/A658 cells. ( A ) Schematic diagram of the integrated GFP transgene in HEK293/A658 cells. A frameshift mutation has been introduced near the ZFN recognition site, leading to premature termination of translation (‘shown as STOP’). Treatment of the mutant cells with a GFP donor template that lacks the first 12 nt of the wild-type cDNA sequence, together with a GFP-targeting ZFN pair, induces homology-directed repair of the mutant locus and functional expression of GFP. ( B ) Representative examples of green fluorescent, GFP gene corrected HEK293/A658 cells after treatment with donor DNA and ZFN expression plasmid, middle column or tf-ZFN1/2, right column. ( C ) Representative flow cytometry plots demonstrating quantification of gene corrected, GFP-positive HEK293/A658 3 days after treatment with the transferrin-ZFN pair (left panel) or donor DNA alone (right panel). Treatment with donor DNA alone results in rare homologous recombination events at the transgene locus. ( D ) Results of independent experiments comparing the gene correction efficiency of ZFN cDNA and transferrin-ZFN-treated HEK293/A658 cells (n = 5 for transferrin-ZFN, ZFN cDNA, and no donor/no nuclease controls; n = 2 for donor/no nuclease control). Prior work has shown that there is no gene correction with nuclease in the absence of donor template .

Journal: Nucleic Acids Research

Article Title: Receptor-mediated delivery of engineered nucleases for genome modification

doi: 10.1093/nar/gkt710

Figure Lengend Snippet: Transferrin-ZFN mediated gene correction in HEK293/A658 cells. ( A ) Schematic diagram of the integrated GFP transgene in HEK293/A658 cells. A frameshift mutation has been introduced near the ZFN recognition site, leading to premature termination of translation (‘shown as STOP’). Treatment of the mutant cells with a GFP donor template that lacks the first 12 nt of the wild-type cDNA sequence, together with a GFP-targeting ZFN pair, induces homology-directed repair of the mutant locus and functional expression of GFP. ( B ) Representative examples of green fluorescent, GFP gene corrected HEK293/A658 cells after treatment with donor DNA and ZFN expression plasmid, middle column or tf-ZFN1/2, right column. ( C ) Representative flow cytometry plots demonstrating quantification of gene corrected, GFP-positive HEK293/A658 3 days after treatment with the transferrin-ZFN pair (left panel) or donor DNA alone (right panel). Treatment with donor DNA alone results in rare homologous recombination events at the transgene locus. ( D ) Results of independent experiments comparing the gene correction efficiency of ZFN cDNA and transferrin-ZFN-treated HEK293/A658 cells (n = 5 for transferrin-ZFN, ZFN cDNA, and no donor/no nuclease controls; n = 2 for donor/no nuclease control). Prior work has shown that there is no gene correction with nuclease in the absence of donor template .

Article Snippet: For conjugation, human holo-transferrin (10 mg in 1 ml of PBS) (Akron Biotechnology, Boca Raton, FL) was reacted with 1 mM sulfosuccinimidyl 6-[3′(2-pyridyldithio)-propionamido] hexanoate (SPDP; Pierce Biotechnology, Rockford, IL, USA) for 1 h at room temperature.

Techniques: Mutagenesis, Sequencing, Functional Assay, Expressing, Plasmid Preparation, Flow Cytometry, Homologous Recombination

Journal: STAR Protocols

Article Title: Protocol for the Maintenance of Quiescent Murine Hematopoietic Stem Cells

doi: 10.1016/j.xpro.2020.100078

Figure Lengend Snippet:

Article Snippet: Recombinant human holo-transferrin , Nacalai Tesque , Cat# 34443-44.

Techniques: Recombinant, Software

(A) A549_Rab11a-mCherry cells were stained for MYOF and imaged. The yellow inset is shown magnified below. Scale bar 10 µm. (B) Pearson’s correlation coefficient analysis between MYOF and Rab11a in single cells, with different shaped points indicating individual cells from different replicates. (C) Western blot of protein expression in siRNA-treated A549 cells 48h post transfection. (D) siRNA-treated A549 cells stained for MYOF 48h post-transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (E) siRNA treated A549_Rab11a-mCherry cells imaged for Rab11a-mCherry 48h post transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (F) siRNA treated A549_Rab11a-mCherry cells transfected for 48h before cells were serum starved for 30’ at 4°C, incubated at 37°C with Atto647-labelled transferrin (Tfn) for 30’ and immediately fixed on ice. Scale bar 10 µm. (G-I) Measurement of the largest signal (G, MYOF; H, Rab11a; I, Tfn) accumulation in each cell, measured by automated thresholding based on image entropy. All experiments consist of 3 biological replicates and error bars represent standard deviation.

Journal: bioRxiv

Article Title: Myoferlin is an essential component of late-stage vRNP trafficking vesicles for enveloped RNA viruses

doi: 10.1101/2024.07.02.601679

Figure Lengend Snippet: (A) A549_Rab11a-mCherry cells were stained for MYOF and imaged. The yellow inset is shown magnified below. Scale bar 10 µm. (B) Pearson’s correlation coefficient analysis between MYOF and Rab11a in single cells, with different shaped points indicating individual cells from different replicates. (C) Western blot of protein expression in siRNA-treated A549 cells 48h post transfection. (D) siRNA-treated A549 cells stained for MYOF 48h post-transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (E) siRNA treated A549_Rab11a-mCherry cells imaged for Rab11a-mCherry 48h post transfection. Maximum intensity Z-stack projections are shown. Scale bar 10 µm. (F) siRNA treated A549_Rab11a-mCherry cells transfected for 48h before cells were serum starved for 30’ at 4°C, incubated at 37°C with Atto647-labelled transferrin (Tfn) for 30’ and immediately fixed on ice. Scale bar 10 µm. (G-I) Measurement of the largest signal (G, MYOF; H, Rab11a; I, Tfn) accumulation in each cell, measured by automated thresholding based on image entropy. All experiments consist of 3 biological replicates and error bars represent standard deviation.

Article Snippet: Human holo-transferrin (Merck; T0665) was conjugated to Atto 647N NHS ester (Merck; 18373), in sodium carbonate buffer, according to manufacturer’s instructions.

Techniques: Staining, Western Blot, Expressing, Transfection, Incubation, Standard Deviation

(A) A549_Rab11a-mCherry cells were transduced with a vector expressing either GFP, EHD1-GFP or EHD2-GFP. They were then infected with MOI 5 WSN for 6h and treated (left) or mock-treated (right) with nucleozin (NCZ) for 2h before fixation and imaging. Scale bar 10 µm. Images are representative of 3 biological replicates. (B) Schematic showing MYOF and EHD1/2 incorporation into vRNP-trafficking ICVs. On the left, in uninfected cells MYOF associates with Rab11a recycling endosomes at the ERC and is actively involved in the transport of cellular components including receptors and transferrin for recycling. On the right, in IAV infected cells the ER is remodelled while vRNPs exported from the nucleus congregate at the MTOC. These vRNPs are trafficked to the cellular membrane for packaging on ICVs containing Rab11a and MYOF, with vesicular maturation possibly triggered by the recruitment of EHD1 and EHD2. ICVs are proposed to traffic to the ERES where vRNPs may then undergo LLPS prior to packaging into virions. PM: Plasma Membrane, MT: Microtubules, ERC: Endosomal Recycling Compartment, ER: Endoplasmic Reticulum, ERES: ER Egress Sites, MTOC: MT Organising Centre, M: Myoferlin, R: Rab11a, E: EHD1/2, LLPS: Liquid-Liquid Phase Separation, ICV: Irregularly Coated Vesicles.

Journal: bioRxiv

Article Title: Myoferlin is an essential component of late-stage vRNP trafficking vesicles for enveloped RNA viruses

doi: 10.1101/2024.07.02.601679

Figure Lengend Snippet: (A) A549_Rab11a-mCherry cells were transduced with a vector expressing either GFP, EHD1-GFP or EHD2-GFP. They were then infected with MOI 5 WSN for 6h and treated (left) or mock-treated (right) with nucleozin (NCZ) for 2h before fixation and imaging. Scale bar 10 µm. Images are representative of 3 biological replicates. (B) Schematic showing MYOF and EHD1/2 incorporation into vRNP-trafficking ICVs. On the left, in uninfected cells MYOF associates with Rab11a recycling endosomes at the ERC and is actively involved in the transport of cellular components including receptors and transferrin for recycling. On the right, in IAV infected cells the ER is remodelled while vRNPs exported from the nucleus congregate at the MTOC. These vRNPs are trafficked to the cellular membrane for packaging on ICVs containing Rab11a and MYOF, with vesicular maturation possibly triggered by the recruitment of EHD1 and EHD2. ICVs are proposed to traffic to the ERES where vRNPs may then undergo LLPS prior to packaging into virions. PM: Plasma Membrane, MT: Microtubules, ERC: Endosomal Recycling Compartment, ER: Endoplasmic Reticulum, ERES: ER Egress Sites, MTOC: MT Organising Centre, M: Myoferlin, R: Rab11a, E: EHD1/2, LLPS: Liquid-Liquid Phase Separation, ICV: Irregularly Coated Vesicles.

Article Snippet: Human holo-transferrin (Merck; T0665) was conjugated to Atto 647N NHS ester (Merck; 18373), in sodium carbonate buffer, according to manufacturer’s instructions.

Techniques: Transduction, Plasmid Preparation, Expressing, Infection, Imaging, Membrane